Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Braud VM, Biton J, Becht E, Knockaert S, Mansuet-Lupo A, Cosson E, Damotte D, Alifano M, Validire P, Anjuère F, Cremer I, Girard N, Gossot D, Seguin-Givelet A, Dieu-Nosjean MC, Germain C.

Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018.

2.

A Real-Time Cytotoxicity Assay as an Alternative to the Standard Chromium-51 Release Assay for Measurement of Human NK and T Cell Cytotoxic Activity.

Fassy J, Tsalkitzi K, Goncalves-Maia M, Braud VM.

Curr Protoc Immunol. 2017 Aug 1;118:7.42.1-7.42.12. doi: 10.1002/cpim.28.

PMID:
28762488
3.

Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates.

Bekri S, Bourdely P, Luci C, Dereuddre-Bosquet N, Su B, Martinon F, Braud VM, Luque I, Mateo PL, Crespillo S, Conejero-Lara F, Moog C, Le Grand R, Anjuère F.

Front Immunol. 2017 Feb 1;8:63. doi: 10.3389/fimmu.2017.00063. eCollection 2017.

4.

A real-time digital bio-imaging system to quantify cellular cytotoxicity as an alternative to the standard chromium-51 release assay.

Fassy J, Tsalkitzi K, Salavagione E, Hamouda-Tekaya N, Braud VM.

Immunology. 2017 Apr;150(4):489-494. doi: 10.1111/imm.12702. Epub 2017 Jan 19.

5.

NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.

Luci C, Bekri S, Bihl F, Pini J, Bourdely P, Nouhen K, Malgogne A, Walzer T, Braud VM, Anjuère F.

PLoS One. 2015 Dec 2;10(12):e0143224. doi: 10.1371/journal.pone.0143224. eCollection 2015.

6.

Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, Fassy J, Bihl F, Poupon G, Lazzari A, Spee P, Anjuère F, Pangault C, Tarte K, Tas P, Xerri L, Braud VM.

Oncoimmunology. 2015 Apr 8;4(8):e1026503. eCollection 2015 Aug.

7.

Silencing of the tandem pore domain halothane-inhibited K+ channel 2 (THIK2) relies on combined intracellular retention and low intrinsic activity at the plasma membrane.

Chatelain FC, Bichet D, Feliciangeli S, Larroque MM, Braud VM, Douguet D, Lesage F.

J Biol Chem. 2013 Dec 6;288(49):35081-92. doi: 10.1074/jbc.M113.503318. Epub 2013 Oct 25.

8.

Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 T cells.

Hervouet C, Luci C, Bekri S, Juhel T, Bihl F, Braud VM, Czerkinsky C, Anjuère F.

Mucosal Immunol. 2014 Mar;7(2):280-91. doi: 10.1038/mi.2013.45. Epub 2013 Jun 26.

PMID:
23801305
9.

B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.

Anjuère F, Bekri S, Bihl F, Braud VM, Cuburu N, Czerkinsky C, Hervouet C, Luci C.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:117-22. doi: 10.1111/j.1469-0691.2012.03995.x. Epub 2012 Aug 10. Review.

10.

Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18.

Prod'homme V, Tomasec P, Cunningham C, Lemberg MK, Stanton RJ, McSharry BP, Wang EC, Cuff S, Martoglio B, Davison AJ, Braud VM, Wilkinson GW.

J Immunol. 2012 Mar 15;188(6):2794-804. doi: 10.4049/jimmunol.1102068. Epub 2012 Feb 15.

11.

Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.

Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, Lazzari A, Neisig A, Håkansson K, Dong T, Wagtmann N, Galsgaard ED, Spee P, Braud VM.

J Biol Chem. 2011 Nov 4;286(44):37964-75. doi: 10.1074/jbc.M111.285312. Epub 2011 Sep 19.

12.

Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Bihl F, Germain C, Luci C, Braud VM.

Cell Mol Life Sci. 2011 Nov;68(21):3457-67. doi: 10.1007/s00018-011-0796-1. Epub 2011 Aug 23. Review.

PMID:
21861183
13.

Natural killer cell responses to infections in early life.

Guilmot A, Hermann E, Braud VM, Carlier Y, Truyens C.

J Innate Immun. 2011;3(3):280-8. doi: 10.1159/000323934. Epub 2011 Mar 12. Review.

14.

Characterization of alternatively spliced transcript variants of CLEC2D gene.

Germain C, Bihl F, Zahn S, Poupon G, Dumaurier MJ, Rampanarivo HH, Padkjær SB, Spee P, Braud VM.

J Biol Chem. 2010 Nov 12;285(46):36207-15. doi: 10.1074/jbc.M110.179622. Epub 2010 Sep 14.

15.

Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection.

Bihl F, Pecheur J, Bréart B, Poupon G, Cazareth J, Julia V, Glaichenhaus N, Braud VM.

J Immunol. 2010 Aug 15;185(4):2174-81. doi: 10.4049/jimmunol.1001486. Epub 2010 Jul 12.

16.

Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi.

Hermann E, Berthe A, Truyens C, Alonso-Vega C, Parrado R, Torrico F, Carlier Y, Braud VM.

Immunology. 2010 Mar;129(3):418-26. doi: 10.1111/j.1365-2567.2009.03194.x. Epub 2009 Nov 16.

17.

Natural killer cell behavior in lymph nodes revealed by static and real-time imaging.

Bajénoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, Germain RN, Glaichenhaus N.

J Exp Med. 2006 Mar 20;203(3):619-31. Epub 2006 Feb 27.

18.

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.

Aldemir H, Prod'homme V, Dumaurier MJ, Retiere C, Poupon G, Cazareth J, Bihl F, Braud VM.

J Immunol. 2005 Dec 15;175(12):7791-5.

19.

Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis.

Hook CE, Telyatnikova N, Goodall JC, Braud VM, Carmichael AJ, Wills MR, Gaston JS.

Clin Exp Immunol. 2004 Oct;138(1):54-60.

20.

Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

Hansasuta P, Dong T, Thananchai H, Weekes M, Willberg C, Aldemir H, Rowland-Jones S, Braud VM.

Eur J Immunol. 2004 Jun;34(6):1673-9.

21.

The T cell surface--how well do we know it?

Evans EJ, Hene L, Sparks LM, Dong T, Retiere C, Fennelly JA, Manso-Sancho R, Powell J, Braud VM, Rowland-Jones SL, McMichael AJ, Davis SJ.

Immunity. 2003 Aug;19(2):213-23.

22.

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I, Maenaka K.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8856-61. Epub 2003 Jul 9.

23.

Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E.

Bland FA, Lemberg MK, McMichael AJ, Martoglio B, Braud VM.

J Biol Chem. 2003 Sep 5;278(36):33747-52. Epub 2003 Jun 23.

24.

Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells.

Braud VM, Aldemir H, Breart B, Ferlin WG.

Trends Immunol. 2003 Apr;24(4):162-4.

PMID:
12697440
25.

Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.

Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR.

Blood. 2003 Jul 15;102(2):577-84. Epub 2003 Jan 30.

26.

HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells.

Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, Streblow DN, Braud VM, Grieser HJ, Belisle JT, Lewinsohn DM.

J Exp Med. 2002 Dec 2;196(11):1473-81.

27.

Cell-surface expression and immune receptor recognition of HLA-B27 homodimers.

Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, Bowness P.

Arthritis Rheum. 2002 Nov;46(11):2972-82.

28.

Viral evasion of natural killer cells during human cytomegalovirus infection.

Braud VM, Tomasec P, Wilkinson GW.

Curr Top Microbiol Immunol. 2002;269:117-29. Review.

PMID:
12224505
29.

Tetrameric complexes of HLA-E, HLA-F, and HLA-G.

Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ.

J Immunol Methods. 2002 Oct 1;268(1):43-50. Review.

PMID:
12213342
30.

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.

31.

Human T cell receptor-mediated recognition of HLA-E.

García P, Llano M, de Heredia AB, Willberg CB, Caparrós E, Aparicio P, Braud VM, López-Botet M.

Eur J Immunol. 2002 Apr;32(4):936-44.

32.

Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes.

Lemberg MK, Bland FA, Weihofen A, Braud VM, Martoglio B.

J Immunol. 2001 Dec 1;167(11):6441-6.

33.

Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors.

Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, Mason DY, van der Merwe PA, McMichael AJ, Bell JI, Powis SH, O'Callaghan CA.

Eur J Immunol. 2000 Dec;30(12):3552-61.

34.

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.

Eur J Immunol. 2000 Jun;30(6):1623-31.

35.

The ILT family of leukocyte receptors.

Allan DS, McMichael AJ, Braud VM.

Immunobiology. 2000 May;202(1):34-41. Review.

PMID:
10879687
36.

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW.

Science. 2000 Feb 11;287(5455):1031.

37.

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.

Braud VM, McMichael AJ.

Curr Top Microbiol Immunol. 1999;244:85-95. Review. No abstract available.

PMID:
10453651
38.

Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.

Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM.

J Exp Med. 1999 Apr 5;189(7):1149-56.

39.

Functions of nonclassical MHC and non-MHC-encoded class I molecules.

Braud VM, Allan DS, McMichael AJ.

Curr Opin Immunol. 1999 Feb;11(1):100-8. Review.

PMID:
10047540
40.

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.

O'Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY.

Mol Cell. 1998 Mar;1(4):531-41.

41.

Differential processing of influenza nucleoprotein in human and mouse cells.

Braud VM, McMichael AJ, Cerundolo V.

Eur J Immunol. 1998 Feb;28(2):625-35.

42.
43.

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.

Nature. 1998 Feb 19;391(6669):795-9.

PMID:
9486650

Supplemental Content

Loading ...
Support Center